CLDI

4.42% 0.0327

Dopo l'orario di chiusura: .73 -0.0419 -5.43%

Calidi Biotherapeutics Inc (CLDI)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Calidi Biotherapeutics Inc

Healthcare (1161)

Biotechnology (651)

(858) 794-9600

4475 Executive Drive, Suite 200, San Diego

Prossima data di guadagno

Ultimi documenti SEC

CLDI's Discussions on Twitter

Confronta CLDI con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CLDI Calidi Biotherapeutics Inc	0.7719	25.52M	0	-23.36M	0	-0.7368
VRTX Vertex Pharmaceuticals Inc	472.27	120.73B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	564.64	61.80B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	328.00	42.46B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	591.74	35.22B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	296.46	31.99B	3.81B	-644.79M	-669.77M	-6.24

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-11-22	Iniziato	H.C. Wainwright	Buy
2023-10-09	Iniziato	Robert W. Baird	Outperform

Calidi Biotherapeutics Inc Borsa (CLDI) Ultime notizie

Calidi Biotherapeutics Inc Azioni (CLDI) Dati Finanziari

Calidi Biotherapeutics Inc (CLDI)

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Confronta CLDI con altri titoli

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

Calidi Biotherapeutics Inc Borsa (CLDI) Ultime notizie

What analysts say about Calidi Biotherapeutics Inc. stockTriple-digit profit margins - jammulinksnews.com

What drives Calidi Biotherapeutics Inc. stock priceDouble or triple returns - Autocar Professional

Calidi Biotherapeutics Inc. Stock Analysis and ForecastRapid return acceleration - jammulinksnews.com

Is Calidi Biotherapeutics Inc. a good long term investmentDynamic investment opportunities - jammulinksnews.com

40-Year Biotech Veteran Jim Schoeneck Joins Connect Biopharma Board as Asthma Drug Enters Critical Phase - Stock Titan

Calidi Biotherapeutics Invites Investors to Webinar on Precision Genetic Medicine Advances - Nasdaq

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on July 24 - GlobeNewswire

What risks could impact Calidi Biotherapeutics Inc. stock performanceFree Stock Trading Community - Newser

What makes Calidi Biotherapeutics Inc. stock price move sharplyFree Professional Portfolio Management - Newser

Why Calidi Biotherapeutics Inc. stock attracts strong analyst attentionFree Best Performing Stock Suggestions - Newser

How Calidi Biotherapeutics Inc. stock performs during market volatilityMarket Beating Strategy - Newser

Calidi Biotherapeutics Inc Inc. (CLDI) Price Performance: A Comparative Analysis with Competitors - investchronicle.com

Calidi Biotherapeutics Approves Key Proposals at Annual Meeting - TipRanks

Calidi Biotherapeutics Plummets 27%—Can Biotech Breakthroughs Stem the Slide? - AInvest

Calidi Biotherapeutics Plunges 4.81% Amid Bridge Financing - AInvest

Top Penny Stocks To Add to Your Watchlist – July 9th - Defense World

Small Cap Stocks Worth Watching – July 9th - Defense World

Calidi Biotherapeutics Announces Inducement Offer Agreement - TipRanks

Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up - Quantisnow

Calidi Biotherapeutics: Redefining Cancer Treatment with Breakthrough Virotherapy - AInvest

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment - The Manila Times

Breakthrough Cancer Treatment: Calidi's New Genetic Platform Targets Both Primary and Metastatic Tumors - Stock Titan

3 Penny Stocks to Watch Now, 7/10/25 - TipRanks

Calidi Biotherapeutics Cashes In On Warrant Agreement - Finimize

Calidi Biotherapeutics secures $4.6 million through warrant exercise - Investing.com Australia

Calidi Biotherapeutics secures $4.6 million through warrant exercise By Investing.com - Investing.com Nigeria

Calidi Biotherapeutics to Raise $4.6 Million Through Warrant Exercise Agreement - MarketScreener

Calidi Biotherapeutics Inc Azioni (CLDI) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a CLDI